325 Capital LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), 325 Capital LLC reported 11 stock positions worth $241.4 million. Its top holding was American Public Education (APEI) at 21.0% of the portfolio, followed by Astronics (ATRO, 17.0%) and Astrana Health (ASTH, 11.4%). Compared with Q4 2024, it opened 1 new position, sold out of 2 and reduced 3. The biggest buy was a new position in Spire Global (SPIR) and the biggest sale an exit from Heartland Express (HTLD).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001873893
- Portfolio Value
- $241.4M (Q1 2025)
- SEC Filing
- 0001214659-25-007810 ↗ filed May 15, 2025
Holdings Value
Holdings 11 stocks · $241.4M
| APEI American Public Education | 20.99% | 2,270,108 | $50.7M | No change |
| ATRO Astronics Corp. | 17.01% | 1,698,916 | $41.1M | Reduce -2.4% |
| ASTH Astrana Health Inc. | 11.39% | 886,916 | $27.5M | No change |
| BLBD Blue Bird Corp. | 10.37% | 773,193 | $25.0M | Reduce -4.8% |
| AIOT Powerfleet Inc. | 8.29% | 3,646,379 | $20.0M | Reduce -1.8% |
| MPAA Motorcar Parts of America Inc. | 7.94% | 2,018,795 | $19.2M | No change |
| LFCR Lifecore Biomedical Inc. | 6.31% | 2,162,466 | $15.2M | No change |
| SPIR Spire Global Inc. | 6.28% | 1,875,000 | $15.2M | New |
| BTMD Biote Corp. Class A | 6.27% | 4,548,127 | $15.1M | No change |
| MULTISENSOR AI HOLDINGS INC | 3.61% | 9,375,000 | $8.7M | No change |
| TACT Transact Technologies Inc. | 1.54% | 1,011,789 | $3.7M | No change |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
| SPIR Spire Global Inc. | New | 6.28% | +6.28 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $419.5M | ASTH, MGNI, APEI, BLBD, SPIR |
| Q1 2026 | 12 | $274.5M | APEI, ASTH, BLBD, MGNI, SPIR |
| Q4 2025 | 13 | $285.4M | APEI, ASTH, MGNI, BLBD, MPAA |
| Q3 2025 | 12 | $329.1M | ATRO, APEI, BLBD, ASTH, MPAA |
| Q2 2025 | 11 | $253.3M | APEI, ATRO, BLBD, MPAA, SPIR |
| Q1 2025 | 11 | $241.4M | APEI, ATRO, ASTH, BLBD, AIOT |
| Q4 2024 | 12 | $258.7M | APEI, BLBD, BTMD, ASTH, ATRO |
| Q3 2024 | 11 | $236.2M | ASTH, BLBD, ATRO, APEI, BTMD |
| Q2 2024 | 13 | $238.1M | BLBD, ATRO, BTMD, ASTH, APEI |
| Q1 2024 | 12 | $216.6M | BLBD, ATRO, SGOV, ASTH, BTMD |